FDA Clears Expanded ENT Indication for J&J’s HARMONIC 1100 Shears – First Johnson & Johnson Ultrasonic Device with 7 mm Vessel Sealing for Otorhinolaryngology

Fineline Cube
3 Min Read
Summarize with AI

Johnson & Johnson (J&J) (NYSE: JNJ) announced that the US Food and Drug Administration (FDA) has cleared an expanded otorhinolaryngology (ENT) indication for the HARMONIC 1100 Shears, the company’s advanced ultrasonic energy platform for tissue dissection and vessel sealing.

- Advertisement -

Regulatory Milestone

ItemDetail
AgencyFDA (United States)
Clearance TypeExpanded indication clearance
ProductHARMONIC 1100 Shears (advanced ultrasonic energy device)
IndicationENT procedures in pediatric and adult patients for the ligation and division of vessels, lymphatics, and tissue bundles
Clearance Date16 Nov 2026
DistinctionFirst J&J ultrasonic device with a 7 mm vessel sealing indication for ENT procedures

Device Profile & Technology

  • Device Class: Sterile, single‑patient‑use advanced ultrasonic energy device for general dissection, vessel sealing, back‑scoring, otomy creation, mesentery marching, and meticulous tissue‑plane dissection.
  • Expanded ENT Capability: The new indication covers pediatric and adult ENT procedures for ligation and division of vessels, lymphatics, and tissue bundles — extending the platform’s addressable procedural footprint.
  • Sealing Performance: The HARMONIC 1100 Shears is the first J&J ultrasonic device to carry a 7 mm vessel sealing indication in ENT, supporting larger‑caliber vessel management in head‑and‑neck surgery.
  • Precision Design: Engineered to deliver minimal thermal spread, supporting the precise tissue management required in anatomically delicate ENT procedures where critical nerves and structures lie close to the operative field.
  • Ergonomics & Control: Features an ergonomic handle, integrated handpiece, and Advanced Hemostasis technology, including dual energy‑delivery buttons that let surgeons switch between focused dissection and coagulation without instrument changes.

Market Impact & Outlook

  • ENT Franchise Expansion: The clearance broadens the HARMONIC platform beyond general surgery into otorhinolaryngology, opening a new procedural vertical for J&J MedTech’s energy‑based surgery portfolio.
  • Pediatric Inclusion: Coverage of pediatric patients is a notable differentiator, as relatively few energy devices carry indications spanning both adult and children’s ENT surgery.
  • Competitive Positioning: With minimal thermal spread and 7 mm sealing capability, the HARMONIC 1100 Shears competes directly against bipolar and ultrasonic rivals on precision — a decisive factor in thyroid, parotid, and skull‑base‑adjacent procedures.
  • Commercial Details: Pricing, launch timing, and international regulatory plans were not disclosed in the announcement.

Forward‑Looking Statements
This brief contains forward‑looking statements regarding commercialization plans, market adoption, and regulatory expectations for the HARMONIC 1100 Shears in ENT procedures. Actual results may differ materially due to risks including hospital purchasing dynamics, competitive energy‑device offerings, surgeon adoption, and evolving clinical practice patterns in otorhinolaryngology.-Fineline Info & Tech

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *